Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GeneChem
AddedFeb 19, 2024
UpdatedJun 28, 2026
GeneChem

GeneChem

GeneChem Inc. specializes in developing health-related substances and bio-medicines using advanced *omics technologies.

HQ
Daejeon, Daejeon, KR
Founded
1997
Overview
Compare
Employees

GeneChem Inc. is specialized in the development of health-related substances such as functional oligosaccharides, new bio-medicines, and gene therapy products, on the basis of the *omics technologies including nucleic acid chemistry, phosphate chemistry, and transglycosylation technology.

Currently, GeneChem Inc. is the only company capable of manufacturing high purity 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) in bulk scale. GeneChem Inc. also manufactures AquaGG® (glyceryl glucoside) of high purity for cosmetic applications.

GeneChem - Similar Companies

Glycos Biotechnologies logo

Glycos Biotechnologies

glycosbio.com

Geneicd logo

Geneicd

Zuchem logo

Zuchem

zuchem.com

Genome & Co logo

Genome & Co

Enzo Biochem logo

Enzo Biochem

Genomatica logo

Genomatica

genomatica.com

Glycomine logo

Glycomine

glycomine.com

NatGlycan logo

NatGlycan

GlycoSurf logo

GlycoSurf

glycosurf.com

Zymochem logo

Zymochem

zymochem.com

GeneExcel logo

GeneExcel

Genecure logo

Genecure

genecure.com

Gene Sciences logo

Gene Sciences

Genicon Sciences logo

Genicon Sciences

Modular Genetics logo

Modular Genetics

GeneChem - Quick Facts

Who are GeneChem's competitors?

Companies similar to GeneChem include Glycos Biotechnologies, Geneicd, Zuchem and Genome & Co.

When was GeneChem founded?

GeneChem was founded in 1997.

Where is GeneChem's headquarters located?

GeneChem's headquarters is located in Daejeon, Daejeon, KR.

How many employees does GeneChem have?

GeneChem has 13 employees as of Feb 10, 2024.

GeneChem - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Europe
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Bio-Medicines
  • Oligosaccharides
Tags
  • Distribution
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 18 more industry codes
NAICS
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research